Staff Reporter
,
Singapore
Auristone
The startup will use the capital to promote its flagship product.
Auristone has secured $5.4m (US$4m) capital from its latest seed funding round led by venture capital firm Elev8.vc.
SEEDS Capital and existing investor Genedant joined the funding round.
The biotech startup focuses on promoting epigenomics in healthcare through its flagship molecular profiling test, “EPI-CALL,” which assists doctors and late-stage cancer patients navigate different therapy options.
The startup will use the raised funds to expand its clinical collaborations and promote EPI-CALL in the market by working with regional genomic companies.
Join Singapore Business Review community
Since you're here...
...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.
We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.
Let us help you drive your business forward with a good partnership!